Literature DB >> 15872222

Detection and typing of Herpes Simplex virus (HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for HSV types 1 and 2.

Lilly Namvar1, Sigvard Olofsson, Tomas Bergström, Magnus Lindh.   

Abstract

Herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) are major causes of mucocutaneous lesions and severe infections of the central nervous system. Here a new semiautomated method for detecting and typing of HSV was used to analyze 479 mucocutaneous swab samples. After DNA extraction using a Magnapure LC robot, a 118-bp segment of the gB region was amplified by real-time PCR utilizing type-specific TaqMan probes to identify HSV-1 or HSV-2. HSV detection in a single well using probes labeled with carboxyfluorescein (FAM) for HSV-1 and JOE (6-carboxy-4',5'-dichloro-2',7'-dimethoxyfluorescein) for HSV-2 had a sensitivity similar to that seen in separate reactions. All but one of 217 samples (99.5%) that had been positive by virus culture were positive by TaqMan PCR, with a correct identification of type in all cases. Out of 262 samples negative by virus culture, 48 (18.3%) were positive by TaqMan PCR, with higher Ct values compared with culture positive samples (P < 0.0001). Overall, the Ct values for HSV-1 were lower than for HSV-2 (mean, 25.5 versus 27.9), but to some extent this could be due to weaker fluorescence by JOE. Lower C(t) values for HSV-1 were seen also in the 202 genital samples (79 HSV-1, 122 HSV-2, 1 HSV-1 and HSV-2), indicating that HSV-1 replicates as well as HSV-2 in the genital area. HSV-1 constituted 40% of genital infections and was associated with lower mean age (29.2 versus 36.4 years), probably reflecting the fact that recurrent genital HSV-1 infections are rare.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15872222      PMCID: PMC1153722          DOI: 10.1128/JCM.43.5.2058-2064.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Rapid detection of herpes simplex virus DNA in genital ulcers by real-time PCR using SYBR green I dye as the detection signal.

Authors:  Carmen Aldea; Carmen P Alvarez; Lola Folgueira; Rafael Delgado; Joaquín R Otero
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Detection of herpes viruses in clinical samples using real-time PCR.

Authors:  S Nicoll; A Brass; H A Cubie
Journal:  J Virol Methods       Date:  2001-07       Impact factor: 2.014

3.  Failure to genotype herpes simplex virus by real-time PCR assay and melting curve analysis due to sequence variation within probe binding sites.

Authors:  Trevor P Anderson; Anja M Werno; Kirsten A Beynon; David R Murdoch
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Rapid detection of herpes simplex virus and varicella-zoster virus infections by real-time PCR.

Authors:  Manfred Weidmann; Ursula Meyer-König; Frank T Hufert
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type.

Authors:  W E Lafferty; R W Coombs; J Benedetti; C Critchlow; L Corey
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

6.  Neuroinvasion by herpes simplex virus. An in vitro model for characterization of neurovirulent strains.

Authors:  T Bergström; E Lycke
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

7.  Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates.

Authors:  Gun-Britt Löwhagen; Petra Tunbäck; Tomas Bergström
Journal:  Acta Derm Venereol       Date:  2002       Impact factor: 4.437

8.  Diagnosing herpesvirus infections by real-time amplification and rapid culture.

Authors:  G J J van Doornum; J Guldemeester; A D M E Osterhaus; H G M Niesters
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Diagnosis of herpesvirus infections of the central nervous system.

Authors:  Stephan W Aberle; Elisabeth Puchhammer-Stöckl
Journal:  J Clin Virol       Date:  2002-07       Impact factor: 3.168

10.  Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2.

Authors:  Hiroshi Kimura; Yoshinori Ito; Masahide Futamura; Yoshihiro Ando; Yumi Yabuta; Yo Hoshino; Yukihiro Nishiyama; Tsuneo Morishima
Journal:  J Med Virol       Date:  2002-07       Impact factor: 2.327

View more
  43 in total

1.  Genotyping of clinical herpes simplex virus type 1 isolates by use of restriction enzymes.

Authors:  Peter Norberg; Tomas Bergström; Jan-Ake Liljeqvist
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

2.  Binding Kinetics and Lateral Mobility of HSV-1 on End-Grafted Sulfated Glycosaminoglycans.

Authors:  Nadia Peerboom; Stephan Block; Noomi Altgärde; Olov Wahlsten; Stephanie Möller; Matthias Schnabelrauch; Edward Trybala; Tomas Bergström; Marta Bally
Journal:  Biophys J       Date:  2017-07-08       Impact factor: 4.033

3.  Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease.

Authors:  Staffan Görander; Ali M Harandi; Madelene Lindqvist; Tomas Bergström; Jan-Åke Liljeqvist
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

4.  STAT4 regulates antiviral gamma interferon responses and recurrent disease during herpes simplex virus 2 infection.

Authors:  Alexandra Svensson; Petra Tunbäck; Inger Nordström; Andrey Shestakov; Leonid Padyukov; Kristina Eriksson
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

5.  Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.

Authors:  Mattias Magnusson; Mikael Brisslert; Kiandoht Zendjanchi; Magnus Lindh; Maria I Bokarewa
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

6.  Host strain-dependent difference in susceptibility in a rat model of herpes simplex type 1 encephalitis.

Authors:  Biborka Bereczky-Veress; Olle Lidman; Farideh Sabri; Ivan Bednar; Fredrik Granath; Tomas Bergström; Christian Spenger; Alf Grandien; Tomas Olsson; Fredrik Piehl; Margarita Diez; Birgit Sköldenberg
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

7.  Divergence and recombination of clinical herpes simplex virus type 2 isolates.

Authors:  Peter Norberg; Mabula J Kasubi; Lars Haarr; Tomas Bergström; Jan-Ake Liljeqvist
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

8.  The Cholestanol-Conjugated Sulfated Oligosaccharide PG545 Disrupts the Lipid Envelope of Herpes Simplex Virus Particles.

Authors:  Joanna S Said; Edward Trybala; Staffan Görander; Maria Ekblad; Jan-Åke Liljeqvist; Eva Jennische; Stefan Lange; Tomas Bergström
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

9.  Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.

Authors:  Aiping Wang; Fang Chen; Yingjie Wang; Mingqiang Shen; Yang Xu; Jian Hu; Song Wang; Fang Geng; Cheng Wang; Xinze Ran; Yongping Su; Tianmin Cheng; Junping Wang
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

10.  Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus.

Authors:  Clare Burn Aschner; Carl Pierce; David M Knipe; Betsy C Herold
Journal:  Vaccines (Basel)       Date:  2020-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.